Learn more about Biogen's strategic realignment from Aduhelm's controversy to Leqembi's promise in Alzheimer's treatment.| Labiotech.eu
The past few years have been challenging for the industry but 2024 might be the year marking the biotech recovery.| Labiotech.eu